Dr. Sandra Salillas is a postdoctoral researcher at the University of Zaragoza, Spain. She received her BS in Biochemistry, and her PhD in Sciences (Biochemistry and Molecular Biology) from the University of Zaragoza in 2014 and 2021, respectively. During her PhD thesis, she worked on the development of new drugs to treat the bacterial infection caused by Helicobacter pylori. After that, she spent two years at Radboudumc, the Netherlands, working on new antibiotic regimens to combat nontuberculous mycobacteria. Currently, she is working at the University of Zaragoza on an international project that aims to accelerate the development of new treatment regimens for tuberculosis. She is a multidisciplinary scientist with 10 years of research experience in drug discovery and development. Her research spans the areas of organic chemistry, biochemistry, microbiology, biophysics, and animal experimentation.
Dr. Sandra Salillas is a postdoctoral researcher at the University of Zaragoza, Spain. She received her BS in Biochemistry, and her PhD in Sciences (Biochemistry and Molecular Biology) from the University of Zaragoza in 2014 and 2021, respectively. During her PhD thesis, she worked on the development of new drugs to treat the bacterial infection caused by Helicobacter pylori. After that, she spent two years at Radboudumc, the Netherlands, working on new antibiotic regimens to combat nontuberculous mycobacteria. Currently, she is working at the University of Zaragoza on an international project that aims to accelerate the development of new treatment regimens for tuberculosis. She is a multidisciplinary scientist with 10 years of research experience in drug discovery and development. Her research spans the areas of organic chemistry, biochemistry, microbiology, biophysics, and animal experimentation.